Articles by Johns Hopkins Medicine

Detecting cancers years before their clinical diagnosis could help provide management with a more favorable outcome

Even small tissue samples can yield additional insights into a tumor’s biology, immune interactions, and molecular pathways

Johns Hopkins Medicine says further research is needed to better understand the problem and find ways to enhance immune response in this high-risk population

The blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer

Researchers also determine that a patient’s race and insurance status play roles in late-stage cancer diagnosis

Liquid biopsy helps screen for ctDNA, which is linked to how patients respond to immuno- and chemo-therapy ​

Researchers used blood and organoids to study the role of mRNA carried by brain-specific EVs in PPD and psychiatric conditions

These biomarkers have the potential to change clinical practice to better predict cardiovascular risk

Researchers identify biomarkers to predict chronic kidney disease risk in hospitalized patients with acute kidney injury

Researchers discover a model of and potential therapeutic target for gastroesophageal junction cancer

Blood testing technology detects 80% of liver cancers in a study of 724 people from the US, EU, and Hong Kong

Researchers identify molecular differences between certain cancer cells

Study finds most patients with pancreatic cancer diagnosed through regular screenings had long-term survival

Quality improvement collaborative highlights a "less is more" method that may prevent antibiotic overprescribing